Price: $49.90
(as of Jun 04, 2025 02:20:36 UTC – Details)
Product Description
PRODUCT DESCRIPTION
Irritable Bowel Syndrome (IBS) is one of the most underestimated, widespread disorders in industrialized countries. IBS patients suffer from diverse symptoms such as constipation, diarrhea, abdominal pain, flatulence, and bloating. In addition, IBS can significantly impair patients’ quality of life.
Unique and Patented Ingredient
After a long research process, European scientists finally found one unique bacteria strain that has been shown to significantly relieve IBS and its symptoms and to simultaneously improve IBS patients’ quality of life. This unique and patented bacteria strain B. bifidum MIMBb75 is only available in Kijimea™ IBS.
Clinically Shown
In a clinical study, B. bifidum MIMB75 has shown to significantly reduce IBS symptoms such as digestive disorder, abdominal pain, discomfort, abdominal distension, bloating, and urgency. In addition, Kijimea™ IBS simultaneously improved the quality of life of IBS patients by a significant margin. Please note that individual results may vary.
Successful Medical Food Finally Available in the USA
In Europe, Kijimea™ IBS has already been very well received among IBS patients. This promising product for the management of IBS is now finally available in the US. So if you have been diagnosed with IBS, Kijimea™ IBS might be an effective help for you.
No Known Side Effects and Allergy-Friendly
So far, no side effects or interactions with other products have been observed in conjunction with the use of Kijimea™ IBS capsules. Kijimea™ IBS does not contain any preservatives, sweeteners, flavoring agents, lactose, or gluten. In addition, Kijimea™ IBS is suitable for a vegan diet.
Is Discontinued By Manufacturer : No
Package Dimensions : 6.06 x 3.62 x 1.42 inches; 1.69 ounces
Item model number : Kijimea IBS
Date First Available : January 26, 2017
Manufacturer : Kijimea
ASIN : B01N23TCPY
UNIQUE & PATENTED BIFIDOBACTERIA STRAIN – Kijimea IBS contains the worldwide unique and patented bacteria strain B. bifidum MIMBb75.
CLINICALLY PROVEN – B. bifidum MIMB75 has been clinically proven (1) to significantly reduce IBS symptoms such as abdominal pain, bloating, constipation, diarrhea, flatulence and urgency. IBS is characterized by chronic digestive problems that can be a great physical and psychological burden for patients.
HIGHER QUALITY OF LIFE – Kijimea IBS significantly improved the quality of life of IBS patients in a clinical study. (1)
NO KNOWN SIDE EFFECTS – Kijimea IBS has no known side effects and no known interactions with other products. It is vegan and without any preservatives, sweeteners, flavoring agents, lactose, or gluten. It is suitable for patients with diabetes.
HIGH-QUALITY PRODUCT – Kijimea IBS is a high-quality product that was developed based on latest scientific research and is manufactured under highest quality standards. It was first introduced in Germany and has already become the most popular IBS product in Europe.
Customers say
Customers report that the supplement starts working within a week and provides relief from IBS symptoms, with one noting it works better than probiotics. The product effectively reduces bloating and gas, and customers consider it a great probiotic. While some customers report significant improvements, others have mixed experiences with their IBS symptoms. The product receives mixed feedback about its value for money, with several customers finding it pricey.
